Edwards Lifesciences Corp (EW) has faced a tumultuous period marked by losses in market capitalization and a series of lawsuits alleging securities fraud. While there have been daily gains observed, the company's stock has consistently underperformed compared to its competitors. Several investment firms increased their stock positions in EW, notable ones include AIA Group Ltd and Kornitzer Capital Management Inc. KS. Despite this, investors have seen a significant 41% loss over the past three years.
Several lawsuits on behalf of investors are in progress, leading to an investor-led class-action lawsuit. The company missed earnings expectations and gave weak guidance, leading to a further downfall in the share price. However, there are optimistic views in the market as well, with Vanguard Group Inc's strategic acquisition of EW shares and a high percentage of institutional ownership. Nonetheless, the company is burdened by pending lawsuits and an overall bearish outlook.
Edwards Lifesciences Corp EW News Analytics from Mon, 03 Jun 2024 07:00:00 GMT to Sat, 09 Nov 2024 15:27:18 GMT - Rating -7 - Innovation -5 - Information 2 - Rumor -5
